UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 190

Sortiert nach

2007 Standards, Options, and Recommendations: Use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer

Pediatric blood & cancer, 2009-07, Vol.53 (1), p.7-12

2009

Link zum Volltext

Verfügbarkeit prüfen

46/1 Haplotype Permits to Follow JAK2 Homologous Recombination: Modeling JAK2V617F clonal Architecture in PV Patients

Blood, 2012-11, Vol.120 (21), p.1757-1757

2012

Link zum Volltext

Verfügbarkeit prüfen

Aluminium Intoxication in the Rat Induces Partial Resistance to the Effect of Recombinant Human Erythropoietin

Nephrology, dialysis, transplantation, 1990, Vol.5 (4), p.258-263

1990

Link zum Volltext

Verfügbarkeit prüfen

Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia

Leukemia research, 1998-06, Vol.22 (6), p.527-535

1998

Link zum Volltext

Verfügbarkeit prüfen

Anti-erythropoietin antibodies and pure red cell aplasia

Journal of the American Society of Nephrology, 2004-02, Vol.15 (2), p.398-406

2004

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against rHuEPO: native and recombinant

Nephrology, dialysis, transplantation, 2002-01, Vol.17 (suppl-5), p.42-47

CASADEVALL, Nicole

2002

Link zum Volltext

Verfügbarkeit prüfen

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent

Nephrology, dialysis, transplantation, 2006-10, Vol.21 (10), p.2963-2965

2006

Link zum Volltext

Verfügbarkeit prüfen

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent

Nephrology, dialysis, transplantation, 2006-11, Vol.21 (11), p.3346-3346

2006

Link zum Volltext

Verfügbarkeit prüfen

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

Kidney international, 2012-04, Vol.81 (8), p.727-732

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options

Nephrology, dialysis, transplantation, 2005-05, Vol.20 (suppl-4), p.iv23-iv26

2005

Link zum Volltext

Verfügbarkeit prüfen

Anticorps anti-érythropoïétine chez des patients insuffisants rénaux traités par l’hormone recombinante

M.S. Médecine sciences, 2002-05, Vol.18 (5), p.542-543

2002

Link zum Volltext

Verfügbarkeit prüfen

Anticorps anti-érythropoïétine chez des patients insuffisants rénaux traités par l’hormone recombinante

M.S. Médecine sciences, 2002-05, Vol.18 (5), p.542-543

2002

Link zum Volltext

Verfügbarkeit prüfen

Aplastic Anemia Responsive to Cyclosporine Complicating the Evolution of Polycythemia Vera

Leukemia & lymphoma, 1999, Vol.33 (5-6), p.607-611

1999

Link zum Volltext

Verfügbarkeit prüfen

Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2465-2471

2006

Link zum Volltext

Verfügbarkeit prüfen

Auto-anticorps spontané anti-érythropoïétine : une cause inhabituelle d'érythroblastopénie

Hématologie (Montrouge), 1997, Vol.3 (2), p.72-75

1997

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell Aplasia

The New England journal of medicine, 1996-03, Vol.334 (10), p.630-633

1996

Link zum Volltext

Verfügbarkeit prüfen

Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro

The Journal of clinical investigation, 1991-09, Vol.88 (3), p.789-797

1991

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune anemia in macaques following erythropoietin gene therapy

Blood, 2004-05, Vol.103 (9), p.3303-3304

2004

Link zum Volltext

Verfügbarkeit prüfen

Autoimmune disorders of erythropoiesis

Current opinion in hematology, 2001-03, Vol.8 (2), p.68-73

2001

Link zum Volltext

Verfügbarkeit prüfen

Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L

Blood, 1999-01, Vol.93 (1), p.125-139

1999

Link zum Volltext

Verfügbarkeit prüfen

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L

Blood, 1999, Vol.93 (1), p.125-139

1999

Link zum Volltext

Verfügbarkeit prüfen

Biosimilaires : de la technique au médicoéconomique

Therapie, 2015-01, Vol.70 (1), p.37-46

2015

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars: from Technical to Pharmacoeconomic Considerations

Therapie, 2015-01, Vol.70 (1), p.47-55

2015

Link zum Volltext

Verfügbarkeit prüfen

Biosimilars need comparative clinical data

Kidney international, 2011-09, Vol.80 (5), p.553-553

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 190

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(118)
Science & Technology
(116)
Life Sciences & Biomedicine
(114)
Biological And Medical Sciences
(68)
Medical Sciences
(62)
Hematology
(48)
Male
(43)
Female
(41)
Hematologic And Hematopoietic Diseases
(37)
Middle Aged
(36)
Recombinant Proteins
(32)
Erythropoietin - Immunology
(31)
Adult
(30)
Aged
(30)
Erythropoietin - Adverse Effects
(26)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(22)
Life Sciences
(22)
Pure Red Cell Aplasia
(22)
Red-Cell Aplasia, Pure - Immunology
(21)
Urology & Nephrology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2007 Standards, Options, and Recommendations: Use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer

46/1 Haplotype Permits to Follow JAK2 Homologous Recombination: Modeling JAK2V617F clonal Architecture in PV Patients

Aluminium Intoxication in the Rat Induces Partial Resistance to the Effect of Recombinant Human Erythropoietin

Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia

Anti-erythropoietin antibodies and pure red cell aplasia

Antibodies against rHuEPO: native and recombinant

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options

Anticorps anti-érythropoïétine chez des patients insuffisants rénaux traités par l’hormone recombinante

Anticorps anti-érythropoïétine chez des patients insuffisants rénaux traités par l’hormone recombinante

Aplastic Anemia Responsive to Cyclosporine Complicating the Evolution of Polycythemia Vera

Arsenic Trioxide in Patients With Myelodysplastic Syndromes: A Phase II Multicenter Study

Auto-anticorps spontané anti-érythropoïétine : une cause inhabituelle d'érythroblastopénie

Autoantibodies against Erythropoietin in a Patient with Pure Red-Cell Aplasia

Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro

Autoimmune anemia in macaques following erythropoietin gene therapy

Autoimmune disorders of erythropoiesis

Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L

Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L

Biosimilaires : de la technique au médicoéconomique

Biosimilars: from Technical to Pharmacoeconomic Considerations

Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondes

Biosimilars need comparative clinical data

Aktive Filter

Suchergebnisse filtern